Benito Therapeutic Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 5 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 1781.36%
- Profit Growth 57.97%
- Ebitda 57.90%
- Net Worth -35.31%
- Total Assets 507.55%
About Benito Therapeutic
Benito Therapeutic Private Limited (BTPL) is a Private Limited Indian Non-Government Company incorporated in India on 19 November 2019 (Five years and two months 22 days old ). Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Tushar Mallick and Manasi Mallick serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24100MH2019PTC333210
-
Company No.
333210
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
19 Nov 2019
-
Date of AGM
15 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Benito Therapeutic?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Tushar Mallick
|
Managing Director | 19-Nov-2019 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Manasi Mallick
|
Director | 19-Nov-2019 | Current |
Financial Performance of Benito Therapeutic.
Benito Therapeutic Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 1781.36% increase. The company also saw a substantial improvement in profitability, with a 57.97% increase in profit. The company's net worth observed a substantial decline by a decrease of 35.31%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Benito Therapeutic?
In 2021, Benito Therapeutic had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Metagenex India Private LimitedTushar Mallick is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Benito Therapeutic?
Benito Therapeutic has a workforce of 20 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Benito Therapeutic, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Benito Therapeutic's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.